Jim Cramer Nailed These 11 Stock Predictions

6. Viking Therapeutics, Inc. (NASDAQ:VKTX)

Number of Hedge Fund Investors: 41

Back then, a humorous caller asked if they should “bulk up” on Viking Therapeutics, Inc. (NASDAQ:VKTX), referencing both weight loss drugs and football. Cramer responded with his trademark flair and a clear preference:

“I even like the Vikings more than I like Viking Therapeutics — and that’s saying something ‘cause they ain’t that good. I say you need to be in Eli Lilly. Step your game up, partner.”

Cramer favored Eli Lilly over Viking, and with VKTX down -52.27%, he made the better call.

Viking Therapeutics, Inc. (NASDAQ:VKTX) is a clinical-stage biopharmaceutical company developing treatments for metabolic and endocrine disorders, including obesity and liver disease.

Cramer remains firm in his opinion. Here’s what he said on January 30 this year:

“Okay, people, people think that even if Lily’s stock can’t go up, why would we want Viking Therapeutics? And a lot of people were in it for a takeover. So far it doesn’t look like that’s materializing, so they’re giving up and they are selling it. I prefer Eli Lilly.”